{{Rsnum
|rsid=3819024
|Gene=IL17A
|Chromosome=6
|position=52185988
|Orientation=plus
|GMAF=0.3669
|Gene_s=IL17A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 39.8 | 43.4 | 16.8
| HCB | 23.5 | 51.5 | 25.0
| JPT | 33.6 | 48.7 | 17.7
| YRI | 46.3 | 44.9 | 8.8
| ASW | 54.4 | 42.1 | 3.5
| CHB | 23.5 | 51.5 | 25.0
| CHD | 22.9 | 47.7 | 29.4
| GIH | 47.5 | 33.7 | 18.8
| LWK | 55.5 | 37.3 | 7.3
| MEX | 46.6 | 51.7 | 1.7
| MKK | 47.4 | 39.7 | 12.8
| TSI | 36.3 | 48.0 | 15.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=23131423
|Title=Interleukin-17A genetic variants can confer resistance to brucellosis in Iranian population
}}

{{PMID Auto
|PMID=22507625
|Title=Association between polymorphisms in cytokine genes IL-17A and IL-17F and development of allergic rhinitis and comorbid asthma in Chinese subjects.
}}

{{PMID Auto
|PMID=24893702
|Title=Interleukin 17A rs3819024 A&gt;G polymorphism is associated with an increased risk of gastric cardia adenocarcinoma in a Chinese population
}}

{{PMID Auto
|PMID=24919468
|Title=Influence of the IL17A locus in giant cell arteritis susceptibility
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}